palliative treatment for severe aortic stenosis. The efficacy of this technique has also been documented by others,9-11 but the evaluation of balloon valvuloplasty in elderly patients with low ejection fractions has only been recently reported. 12 The aim of this study was to assess the safety, efficacy, and midterm clinical follow-up of aortic valvuloplasty in patients with severe calcific aortic stenosis and a left ventricular ejection fraction below 40%, which is usually considered severely depressed. 13 '14 Methods Patients From September 1985 to March 1987, balloon aortic valvuloplasty was performed in 218 consecutive patients in our institution. Of this population, 55 consecutive patients (38 men and 17 women) were reviewed for this study because of a prevalvuloplasty left ventricular angiographic ejection fraction below 40% (mean, 29+7%). Their mean age was 77±9 years, with 20 patients older than 80 years of age.
All patients were markedly disabled. Fifty-two patients had marked dyspnea (New York Heart Association functional Class III or IV). Angina was present in 24 patients, and syncope with exercise was present in 15 patients.
Twenty-one patients exhibited refractory congestive heart failure despite intensive medical therapy, including an infusion of dobutamine in two patients at the time of catheterization. Balloon valvuloplasty was proposed to the patient in the same setting of the diagnostic cardiac catheterization.
Coronary arteriography was performed after the valvuloplasty in 17 of 24 patients with angina. Seven patients had normal results on the coronary angiogram, two exhibited single-vessel disease, one had double-vessel disease, and seven had triple-vessel disease. Because of their critical status or because of their age (>80 years), coronary angiography was deliberately not performed in the 31 patients without angina and in seven patients with angina.
Catheterization Protocol
The protocol has been previously published.7 Briefly, right heart catheterization was performed with a 7F Swan-Ganz thermodilution catheter placed in the left femoral vein, and left heart catheterization was done in most cases with a Sones catheter (USCI, Billerica, Massachusetts) placed in the femoral artery (n=52) or right humeral artery (n=3).
After placement of all catheters, right atrial, pulmonary arterial, systemic arterial, and left ventricular pressures were measured. Aortic and left ventricular pressures were recorded simultaneously on a Siemens Mingograph for evaluation of the peak to peak gradient and for further computation of the mean aortic valve systolic gradient. After pressures were recorded, the cardiac output was determined by the thermodilution technique (mean of at least three consecutive measurements), and right anterior oblique left ventricular angiography was subsequently performed.
After removal of the left ventricle catheter, a valvuloplasty balloon catheter (Mansfield, Boston, Massachusetts) was introduced transcutaneously and was positioned across the valve. The diameter of the first balloon used was 8 mm in one patient, 12 mm in two patients, 15 
Results

Initial Hemodynamic and Angiographic Evaluation
In all patients, hemodynamic measurements have confirmed the presence of severe aortic stenosis with advanced heart failure ( Hemodynamic improvement was also confirmed by the significant decrease in systolic pulmonary pressure from 59±25 to 43±17 mm Hg (p<0.001). In the 38 patients who could undergo postvalvuloplasty left ventricular angiography, there was a significant increase in angiographic ejection fraction from 29±6% to 35±10% (p<0.001). Eighteen patients had an increase in ejection fraction greater than 5%, and 20 patients had no change or a decrease in ejection fraction. Among the 48 patients who had a supravalvular aortogram performed after valvuloplasty, no change in the severity of aortic regurgitation was seen in 40. Four patients had a grade 3 aortic insufficiency when they had either grade 1 (n=2) or grade 2 (n=2) before. ized because they were symptomatic again, and 12 patients were systematically restudied, though they were doing well. Restenosis was defined as more than 50% loss of the gain in valve area obtained by valvuloplasty. By that definition, nine patients (45%) had restenosis (six of the eight patients with symptoms again), and 11 did not have restenosis.
In patients with restenosis, the aortic valve area had almost returned to prevalvuloplasty values (0.50+0.27 cm2 initially vs. 0.58±0.20 at control, NS) (Table 3) . Despite restenosis, the ejection fraction had increased from 34+3% to 43+11% (NS). The hemodynamic variables of the patients with no restenosis are shown in Figure 4 . Aortic valve area at control (0.73±0.17 cm2) was comparable to the postvalvuloplasty result (0.74±0.15 cm2, NS). Peak to peak systolic pressure gradient had increased from 38 mm Hg after valvuloplasty to 54 mm Hg at control (p<0.01). This increase was due to the improvement in ventricular function as shown by the increase in cardiac index from 2.6±0.4 to 3.1+0. 8 In this series, the percent increase in valve area was 82%, and the post valvuloplasty valve area was 0.83+0.27 cm2 with 20 patients having a valve area less than 0.7 cm2. This is comparable to the 90% increase obtained in our first 66 patients with normal left ventricular function.7 However, in patients with a low cardiac output, the accuracy of the Gorlin formula is decreased and in that situation, this formula seems to systematically underestimate the true valve area.19 Therefore some of the valve areas after dilatation could actually be larger.
The low mortality rate during the procedure despite the severe condition of these patients has to be emphasized. The 5% mortality rate in hospital (three patients) should compare favorably with the surgical mortality rate. In fact, no real comparison with surgery is possible because 45 of these patients were not considered suitable for valve replacement, whereas the 10 remaining patients were high risk. Concerning age only, in one recent published surgical series,6 30% of octogenarian patients died early after aortic valve replacement. Concerning patients with aortic stenosis and low ejection fraction, in four surgical series,4,5,'71'8 though the mean ages of patients were clearly lower in three (59, 62, and 65 years) than in our series and although their condition was less critical, the mortality rate was 15%, 21%, 25%, and 20%, respectively. Undoubtedly, however, the surgical risk has decreased in recent years. The most recently published surgical series on aortic stenosis with low ejection fraction (20 patients) gives a 5% mortality rate, but the patients were clearly younger (mean age, 66 years), and all had normal coronary arteries.20
In 18 out of our 38 patients who had a second left ventricular angiogram performed immediately after valvuloplasty, ejection fraction significantly rose immediately after dilatation from 28+6% to 39+9%, which is a 40% increase (p<0.001). This seems to confirm that in these cases afterload mismatch was the principal cause of the decreased left ventricular ejection fraction.14,21 For the other patients in whom no significant change in ejection fraction could be found, other mechanisms for alteration of myocardial function (i.e., myocardial hypertrophy, diffuse coronary disease, coexistent cardiomyopathy) and insufficient valvular dilatation could explain the absence of immediate improvement in systolic function. For the 10 patients who had redilatation either because they had restenosis or because the initial result was not good, the increase of the valve area was slight, from 0.65 to 0.77 cm2, and represented a 20% increase, which suggests that a second valvuloplasty procedure does not clearly improve the aortic valve area.
Limitations
Systematic invasive or noninvasive evaluation of the 35 patients who declined to return to repeat catheterization or died before 6 months would have strengthened the present study. However, their clinical follow-up records were examined. If we assumed that all the patients who died within 6 months (n = 17) and that all the patients with symptoms again during the same period of time (n =8) had restenosis, our clinical restenosis rate would also be 47%, which is comparable to the hemodynamic restenosis rate in our 20 patients with repeat catheterization. Nevertheless, it should be recognized that the 20 patients restudied by cardiac catheterization may not be representative of the entire group.
Conclusion
These results indicate that aortic balloon valvuloplasty is a low-risk procedure in 
